HeartBeam Inc. (NASDAQ: BEAT) will host a conference call on May 13 to discuss its first quarter 2025 financial results and provide a strategic business update. CEO Robert Eno and CFO Timothy Cruickshank will lead the presentation, offering insights into the company's ongoing developments in cardiac health technology.
The conference call will focus on the company's progress in developing an innovative portable cardiac diagnostic platform. HeartBeam is pioneering a cable-free 12-lead ECG device capable of capturing three-dimensional heart electrical signals outside traditional medical facilities. This technology represents a significant advancement in remote cardiac monitoring and patient care.
With 13 U.S. and 4 international patents, HeartBeam is positioning itself at the forefront of cardiac health management technology. The company's platform aims to enable physicians to identify cardiac health trends and acute conditions more efficiently, potentially transforming how heart health is monitored and diagnosed.
Investors and healthcare professionals can expect detailed updates on regulatory milestones, commercial readiness strategies, and the company's upcoming technological developments during the conference call. A corresponding press release and presentation will be made available on HeartBeam's investor relations website.
